CRISPR

CRISPR1-hpdl

ID
ZDB-CRISPR-251201-1
Name
CRISPR1-hpdl
Previous Names
None
Target
Sequence
5' - GGGAGCTGTCGATGAGTGTG - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
No data available
Expression
Gene expression in Wild Types + CRISPR1-hpdl
No data available
Phenotype
Phenotype resulting from CRISPR1-hpdl
Phenotype Fish Figures
head apoptotic process increased process quality, abnormal AB + CRISPR1-hpdl Fig. 3 with image from Mero et al., 2025
head reactive oxygen species increased amount, abnormal AB + CRISPR1-hpdl Fig. 3 with image from Mero et al., 2025
locomotion decreased process quality, abnormal AB + CRISPR1-hpdl Fig. 3 with image,  Fig. 4 with image from Mero et al., 2025
post-vent region apoptotic process increased process quality, abnormal AB + CRISPR1-hpdl Fig. 3 with image from Mero et al., 2025
swimming behavior increased process quality, abnormal AB + CRISPR1-hpdl Fig. 3 with image,  Fig. 4 with image from Mero et al., 2025
Phenotype of all Fish created by or utilizing CRISPR1-hpdl
Phenotype Fish Conditions Figures
locomotion decreased process quality, abnormal AB + CRISPR1-hpdl control Fig. 3 with image,  Fig. 4 with image from Mero et al., 2025
locomotion process quality, ameliorated AB + CRISPR1-hpdl chemical treatment by environment: 4-hydroxymandelic acid Fig. 4 with image from Mero et al., 2025
swimming behavior increased process quality, abnormal AB + CRISPR1-hpdl control Fig. 3 with image,  Fig. 4 with image from Mero et al., 2025
swimming behavior increased process quality, abnormal AB + CRISPR1-hpdl chemical treatment by environment: 4-hydroxybenzoic acid Fig. 4 with image from Mero et al., 2025
swimming behavior process quality, ameliorated AB + CRISPR1-hpdl chemical treatment by environment: 4-hydroxymandelic acid Fig. 4 with image from Mero et al., 2025
head apoptotic process increased process quality, abnormal AB + CRISPR1-hpdl control Fig. 3 with image from Mero et al., 2025
post-vent region apoptotic process increased process quality, abnormal AB + CRISPR1-hpdl control Fig. 3 with image from Mero et al., 2025
head reactive oxygen species increased amount, abnormal AB + CRISPR1-hpdl control Fig. 3 with image from Mero et al., 2025
locomotion decreased process quality, abnormal AB + CRISPR1-hpdl chemical treatment by environment: 4-hydroxybenzoic acid Fig. 4 with image from Mero et al., 2025
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.